Genome-wide analysis of the South African Coloured population in the Western Cape

Molecular Biology and Human Genetics, MRC Centre for Molecular and Cellular Biology, DST/NRF Centre of Excellence for Biomedical TB Research, Faculty of Health Sciences, Stellenbosch University, PO Box 19063, Tygerberg, 7505, South Africa.
Human Genetics (Impact Factor: 4.82). 08/2010; 128(2):145-53. DOI: 10.1007/s00439-010-0836-1
Source: PubMed


Admixed populations present unique opportunities to discover the genetic factors underlying many multifactorial diseases. The geographical position and complex history of South Africa has led to the establishment of the unique admixed population known as the South African Coloured. Not much is known about the genetic make-up of this population, and the historical record is patchy. We genotyped 959 individuals from the Western Cape area, self-identified as belonging to this population, using the Affymetrix 500k genotyping platform. This resulted in nearly 75,000 autosomal SNPs that could be compared with populations represented in the International HapMap Project and the Human Genome Diversity Project. Analysis by means of both the admixture and linkage models in STRUCTURE revealed that the major ancestral components of this population are predominantly Khoesan (32-43%), Bantu-speaking Africans (20-36%), European (21-28%) and a smaller Asian contribution (9-11%), depending on the model used. This is consistent with historical data. While of great historical and genealogical interest, this information is also essential for future admixture mapping of disease genes in this population.

Download full-text


Available from: Marlo Möller
    • "Race distribution was as follows: mixed ancestry (n = 82, 77%), black (n = 15, 14%) and white (n = 10, 9%). The South African mixed ancestry population, or socalled South African Coloured population, is a unique population with a complex genetic history that is largely made up of Khoisan genes admixed with African, European and a smaller Asian contribution [11]. Patients who self-identified as South African Coloured were included under mixed ancestry category. "

    No preview · Article · Sep 2015
  • Source
    • "The older Khoisan populations based in the South-Western parts of Africa make up the remaining African population. In South Africa, there is also a Cape mixed ancestry population, which originated from the sub-Saharan African Bantu-speakers, with influences from both Europe and Asia (de Wit et al., 2010). When two Bantu-speaking populations from Cameroon and South Africa were compared, they were found to be genetically similar with regard to CYP2A6 and CYP2B6. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract The CYP450 and UGT enzymes are involved in phase I and phase II metabolism of the majority of clinically prescribed drugs, including the non-nucleoside reverse transcriptase inhibitors, efavirenz and nevirapine, used in the treatment of HIV/AIDS. Variations in the activity of these enzymes due to gene polymorphisms can affect an individual's drug response or may lead to adverse drug reactions. There is an inter-ethnic distribution in the frequency of these polymorphisms, with African populations exhibiting higher genetic diversity compared to other populations. African specific alleles with clinical relevance have also emerged. Given the high prevalence of HIV/AIDS in sub-Saharan Africa, understanding the frequency of pharmacogenetically relevant alleles in populations of African origin, and their impact on efavirenz and nevirapine metabolism, is becoming increasingly critical. This review aims to investigate ethnic variation of CYP2B6, CYP2A6 and UGT2B7, and to understand the pharmacogenetic relevance when comparing frequencies in African populations to other populations worldwide.
    Full-text · Article · Nov 2014 · Drug Metabolism Reviews
  • Source
    • "Briefly, Bellville South is predominantly a mixed ancestry township located in the northern suburb of Cape Town in the Tygerberg subdistrict. The mixed ancestry, commonly referred to as coloured, is a South African population group with 32–43% Khoisan, 20–36% Bantu-speaking African, 21–28% European, and 9–11% Asian ancestry [14]. All participants received a standardized interview and physical examination during which blood pressure was measured according to the World Health Organisation (WHO) guidelines [15] using a semiautomated digital blood pressure monitor (Rossmax PA, USA) on the right arm in a sitting position. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. Genetic variants in the nuclear transcription receptor, PPARG, are associated with cardiometabolic traits, but reports remain conflicting. We determined the frequency and the clinical relevance of PPARG SNPs in an African mixed ancestry population. Methods. In a cross-sectional study, 820 participants were genotyped for rs1800571, rs72551362, rs72551363, rs72551364, and rs3856806, using allele-specific TaqMan technology. The homeostatic model assessment of insulin (HOMA-IR), β-cells function (HOMA-B%), fasting insulin resistance index (FIRI), and the quantitative insulin-sensitivity check index (QUICKI) were calculated. Results. No sequence variants were found except for the rs3856806. The frequency of the PPARG-His447His variant was 23.8% in the overall population group, with no difference by diabetes status ( P = 0.215 ). The His447His allele T was associated with none of the markers of insulin resistance overall and by diabetes status. In models adjusted for 2-hour insulin, the T allele was associated with lower prevalent diabetes risk (odds ratio 0.56 (95% CI 0.31–0.95)). Conclusion. Our study confirms the almost zero occurrences of known rare PPARG SNPs and has shown for the first time in an African population that one of the common SNPs, His447His, may be protective against type 2 diabetes.
    Full-text · Article · Aug 2014 · International Journal of Endocrinology
Show more